AllRock Bio is a drug developing firm that offers novel therapies to patients suffering hypertension and other fibrotic conditions.
AllRock Bio has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in September 2025.
AllRock Bio's investors include Versant Ventures, Westlake Village BioPartners.
AllRock Bio is headquartered in Boston, United States.
AllRock Bio is a drug developing firm that offers novel therapies to patients suffering hypertension and other fibrotic conditions.
AllRock Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AllRock Bio — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/allrock-bio. Accessed August 14, 2026.
VCBacked. (2025). AllRock Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/allrock-bio
{{cite web |title=AllRock Bio — Funding & Investors |url=https://www.vcbacked.co/company/allrock-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated